# Cancer incidence and mortality in Quito, 1985 to 2017, from the Quito population-based registry

Source: https://onco.cc/key-papers/paper-cueva-quito-cancer-incidence-1985-2017-colomb-med-2022/  
OnCo record `paper-cueva-quito-cancer-incidence-1985-2017-colomb-med-2022` (Key paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Quito's cancer registry counted 93,821 new cancers from 1985 to 2017; incidence rose by about 2% a year in both sexes and mortality by 2.0% a year in men and 1.3% in women, with breast, prostate, colorectal, thyroid cancer and lymphoma increasing and the fall in cervical and stomach cancer stalling.

## Summary

Published as "Cancer incidence and mortality in Quito: information to monitor cancer control policies". The authors, from the Registro Nacional de Tumores at SOLCA Quito, analysed age-standardised incidence and mortality in the city of Quito from 1985 to 2017 with joinpoint regression, and discussed the results against Ecuador's 2017 national cancer strategy. Mortality figures come from the national statistics institute and are checked against the registry's own case records.

## Fields

- Kind: Key paper
- Last checked: 2026-11-11
- Journal: Colombia Médica
- Year: 2022
- DOI: 10.25100/cm.v53i1.4929
- Authors: Cueva P, Tarupi W, Caballero H.
- Findings: 93,821 new cancers were diagnosed among Quito residents from 1985 to 2017, rising from 1,355 in 1985 to 5,846 in 2017.; Incidence rose by an annual 2.0% in men and 2.0% in women, and mortality by 2.0% in men and 1.3% in women.; For 2013 to 2017, incidence excluding non-melanoma skin cancer was 212.2 per 100,000 men and 227.3 per 100,000 women; thyroid (47.0) and breast (41.8) led in women, prostate (63.0) and stomach (19.5) in men.
- What it means: The latest published rates from the Quito registry, which predates Ecuador's other population-based registries. They show thyroid cancer overtaking breast cancer in Quito's women and cervical and stomach cancer no longer falling, which the authors read as a reason to strengthen prevention.
- Caveats: One city, about 1.9 million people in 2017; Quito's rates are higher than IARC's national estimate.; Five high-quality registries cover 41.4% of Ecuador's population, so most of the country is not counted directly.

## Sources

- Colomb Med 2022: https://doi.org/10.25100/cm.v53i1.4929
- PubMed: https://pubmed.ncbi.nlm.nih.gov/36415599/
- Europe PMC full text (PMC9651078): https://europepmc.org/article/PMC/PMC9651078

## Connected records

- cancers: [Breast cancer (all types)](https://onco.cc/cancers/breast-cancer/), [Cervical cancer](https://onco.cc/cancers/cervical/), [Colorectal cancer](https://onco.cc/cancers/colorectal/), [Gastric & gastro-oesophageal junction cancer](https://onco.cc/cancers/gastric/), [Prostate cancer](https://onco.cc/cancers/prostate/), [Thyroid cancer](https://onco.cc/cancers/thyroid/)
- institutions: [Ministerio de Salud Pública del Ecuador](https://onco.cc/institutions/msp-ecuador/), [Registro Nacional de Tumores (Quito population-based cancer registry)](https://onco.cc/institutions/registro-nacional-de-tumores-ecuador/), [SOLCA Núcleo de Quito, Hospital Oncológico Solón Espinosa Ayala](https://onco.cc/institutions/solca-quito/)

---
JSON: https://onco.cc/api/v1/entities/paper-cueva-quito-cancer-incidence-1985-2017-colomb-med-2022.json